Medi Assist Healthcare Intrinsic Value
MEDIASSIST Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹129.57 | ₹103.66 - ₹155.48 | -70.0% | EPS: ₹4.52, Sector P/E: 12x |
| Book Value Method | asset | ₹157.71 | ₹141.94 - ₹173.48 | -63.5% | Book Value/Share: ₹157.71, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹214.86 | ₹193.37 - ₹236.35 | -50.3% | Revenue/Share: ₹268.57, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹287.10 | ₹258.39 - ₹315.81 | -33.5% | EBITDA: ₹168.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹366.05 | ₹292.84 - ₹439.26 | -15.2% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹129.57 | ₹116.61 - ₹142.53 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹129.57 | ₹116.61 - ₹142.53 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹215.95 | ₹194.35 - ₹237.55 | -50.0% | ROE: 5.8%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹129.57 | ₹116.61 - ₹142.53 | -70.0% | EPS: ₹4.52, BVPS: ₹157.71 |
Want to compare with current market value? Check MEDIASSIST share price latest .
Valuation Comparison Chart
MEDIASSIST Intrinsic Value Analysis
What is the intrinsic value of MEDIASSIST?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Medi Assist Healthcare (MEDIASSIST) is ₹157.71 (median value). With the current market price of ₹431.90, this represents a -63.5% variance from our estimated fair value.
The valuation range spans from ₹129.57 to ₹366.05, indicating ₹129.57 - ₹366.05.
Is MEDIASSIST undervalued or overvalued?
Based on our multi-method analysis, Medi Assist Healthcare (MEDIASSIST) appears to be trading above calculated value by approximately 63.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.36 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.10 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 5.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.81x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Medi Assist Healthcare
Additional stock information and data for MEDIASSIST
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹138 Cr | ₹29 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹66 Cr | ₹39 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹81 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹64 Cr | ₹23 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹139 Cr | ₹109 Cr | Positive Free Cash Flow | 8/10 |